Vaccine Therapy in Treating Patients With Melanoma

NCT00003556 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

NIH

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: ALVAC-hB7.1
BIOLOGICAL: canarypox-hIL-12 melanoma vaccine

Sponsor

National Cancer Institute (NCI)